Kevin M. Sun - Sep 6, 2022 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Chief Financial Officer
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
Sep 6, 2022
Transactions value $
-$967
Form type
4
Date filed
9/8/2022, 08:06 PM
Previous filing
Mar 25, 2022
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale -$967 -178 -0.08% $5.43 223K Sep 6, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
F2 Includes 1,953 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2022.